“AI-Powered Pathology and Remote Diagnostics”
- A significant and accelerating trend in the global whole slide imaging (WSI) market is the integration of artificial intelligence (AI) and cloud-based telepathology platforms, which is revolutionizing how pathological data is interpreted, shared, and stored. These technologies are enhancing diagnostic accuracy, turnaround time, and collaboration among healthcare professionals across geographies
- For instance, platforms such as Proscia’s Concentriq and Paige.AI’s digital pathology tools utilize AI-powered algorithms to assist pathologists in detecting cancerous tissues, reducing interpretation errors and expediting workflows
- AI in WSI enables real-time quantification of biomarkers, pattern recognition in tissue morphology, and predictive diagnostics, which are proving especially beneficial in oncology and research settings. Some systems also allow for automated case prioritization based on slide abnormalities, improving lab efficiency
- Telepathology capabilities are further enhanced by high-resolution slide viewers and cloud integration, which allow seamless remote consultations and second opinions, particularly in underserved or rural regions
- The combination of WSI with digital health platforms and AI analytics is creating a unified pathology ecosystem where clinicians, researchers, and institutions can collaborate more efficiently
- This trend toward intelligent, remote-access pathology is driving demand for scalable, interoperable, and regulatory-compliant WSI solutions across both clinical and research domains, with major vendors such as Leica Biosystems and Philips focusing on AI-integrated imaging workflows
